Induction Healthcare to Acquire Patient Engagement Platform Firm Zesty.

MANews-(C)2009-2020

UK-based Induction Healthcare Group plc (LSE: INHC) has entered into a conditional share purchase agreement to acquire digital healthcare patient engagement platform company Zesty Ltd for a consideration comprising GBP 500,000 in cash plus the issue of 12,424,527 new ordinary shares, the company said.

Based on the mid-market closing price of the stock on 18 May 2020, the 12,424,527 new ordinary shares to be issued pursuant to the acquisition is equivalent to approximately GBP 12.2m and therefore the aggregate purchase price is equivalent to approximately GBP 12.7m (USD 15.37m).

Zesty's platform provides an integration layer with a hospital's electronic patient record or patient administration system and a portal that allows patients to manage their hospital outpatient appointments, read their administrative and clinical correspondence, attend a video based consultation and store a personal copy of their clinical record, through this...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT